Endocrine prevention of breast: any role for tibolone?
Kloosterboer
H J
HJ
NV Organon, Research and Development Laboratories, PO Box 20, 5340 BH Oss, The Netherlands. lenus.kloosterboer@organon.com
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000009:adverse effects; D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D002273:Carcinogens / Q000009:adverse effects; D005260:Female; D006801:Humans; D009368:Neoplasm Transplantation; D009652:Norpregnenes / Q000627:therapeutic use*; D051381:Rats
D018931:Antineoplastic Agents, Hormonal; D002273:Carcinogens; D009652:Norpregnenes; D015127:9,10-Dimethyl-1,2-benzanthracene; C027385:tibolone